The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis

Published:2018-08-21 Issue:2 Volume:58 Page:e3-e42
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Holroyd Christopher R¹,Seth Rakhi¹,Bukhari Marwan²,Malaviya Anshuman³,Holmes Claire¹,Curtis Elizabeth⁴,Chan Christopher¹,Yusuf Mohammed A³,Litwic Anna⁴⁵,Smolen Susan³,Topliffe Joanne³,Bennett Sarah¹,Humphreys Jennifer⁶,Green Muriel⁷,Ledingham Jo⁸

Affiliation:

1. Rheumatology Department, University Hospital Southampton NHS Foundation Trust, Southampton, UK

2. Rheumatology Department, University Hospitals of Morecombe Bay NHS Foundation Trust, Lancaster, UK

3. Rheumatology Department, Mid Essex hospitals NHS Trust, Chelmsford, UK

4. MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK

5. Rheumatology Department, Salisbury District Hospital, Salisbury, UK

6. Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, UK

7. National Rheumatoid Arthritis Society, Queen Alexandra Hospital, Portsmouth, UK

8. Rheumatology Department, Queen Alexandra Hospital, Portsmouth, UK

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/58/2/e3/27583773/key208.pdf

Reference297 articles.

1. BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies;Ding;Rheumatology,2010

2. BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis;Bukhari;Rheumatology,2011

3. The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis;Malaviya;Rheumatology,2014

4. Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001);Ledingham;Rheumatology,2005

5. BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs;Ledingham;Rheumatology,2017

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary hypogammaglobulinemia: diagnosis and management of a pediatric condition of clinical importance;Current Opinion in Pediatrics;2024-09-03

2. Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis;Autoimmunity Reviews;2024-09

3. A Systematic Overview of Contraindications and Special Warnings for Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Establishing a Framework to Create a “Safety Checklist”;Drug Safety;2024-07-16

4. The value of patient-initiated follow up: insights from a highly specialised service;British Journal of Healthcare Management;2024-07-02

5. [Translated article] Recommendations from the Spanish Academy of Dermatology and Venereology Psoriasis Working Group on the Management of Patients with Cancer and Psoriasis;Actas Dermo-Sifiliográficas;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3